Hexafluorenium Bromide
Title: Hexafluorenium Bromide
CAS Registry Number: 317-52-2
CAS Name: N,N¢-Di-9H-fluoren-9-yl-N,N,N¢,N¢-tetramethyl-1,6-hexanediaminium dibromide
Additional Names: hexamethylenebis[9-fluorenyldimethylammonium bromide]; hexamethylenebis(dimethyl-9-fluorenylammonium bromide)
Trademarks: Mylaxen
Molecular Formula: C36H42Br2N2
Molecular Weight: 662.54
Percent Composition: C 65.26%, H 6.39%, Br 24.12%, N 4.23%
Literature References: Neuromuscular blocking agent with pseudocholinesterase inhibitory activity. Prepn: Cavallito et al., J. Am. Chem. Soc. 76, 1862 (1954); Cavallito, Gray, US 2783237 (1957 to Irwin, Neisler). Clinical trial for prolongation of succinylcholine muscular block: L. F. Walts et al., Anesthesiology 33, 503 (1970). Review: R. M. Britton, M. Figueroa, Anesth. Analg. 52, 100-105 (1973).
Properties: Crystals from n-propanol, mp 188-189°.
Melting point: mp 188-189°
Therap-Cat: Succinylcholine synergist.
Keywords: Succinylcholine Synergist.

Others monographs:
MinocyclineCethexonium BromideCalcium OxideDasatinib
Pro-DroneThiosinamineCyproquinateLosartan
AlfimepraseSpectrinLevophacetoperaneCephapirin Sodium
WarfarinChromium(III) OxideSodium HexafluorosilicateCorycavidine
©2016 DrugLead US FDA&EMEA